Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 110 citing Yokokawa: Increased nitric oxide production in patients with hypotension during hemodialysis. (0.22 sec) 

Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End- …

- asnjournals.org
JANT KIELSTEIN, RH BOGER, SM BODE- … - Journal of the American …, 1999 - Am Soc Nephrol
Abstract. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelial nitric
oxide (NO) synthase. Its concentration is elevated in patients with end-stage renal disease
(ESRD), in part because it is excreted via the kidneys. In this study, the plasma ...
Cited by 253 - Related articles - BL Direct - All 18 versions

Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal …

- oxfordjournals.org [PDF] 
RJ MacAllister, MH Rambausek, P Vallance, D … - Nephrology Dialysis …, 1996 - ERA-EDTA
RJ MacAllister 1 , MH Rambausek 3 , P. Vallance 2 , D. Williams 2 , K.-H. Hoffmann 3 and E.
Ritz 3 ... 'Department of Pharmacology and Clinical Pharmacology, St George's Hospital Medical
School, London, 2 Centre for Clinical Pharmacology, Cruciform Project, University ...
Cited by 142 - Related articles - BL Direct - All 3 versions

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated …


MF Hand, WG Haynes, DJ Webb - Kidney international, 1998 - nature.com
Received 30 May 1997; Revised 10 November 1997; Accepted 17 November 1997. ... Hemodialysis
and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. In
end-stage renal failure (ESRF) symptomatic hemodialysis-related hypotension may ...
Cited by 104 - Related articles - BL Direct - All 4 versions

Hemodynamic changes during a single treatment with the molecular adsorbents …


LE Schmidt, VR Sørensen, LB Svendsen, BA Hansen, … - Hepatology - interscience.wiley.com
The aim of this pilot study is to evaluate the circulatory safety of treatment with the molecular
adsorbents recirculating system (MARS) by determining the effect on systemic hemodynamics
of a single MARS treatment in patients with acute-on-chronic liver failure (AOCLF). In ...
Cited by 98 - Related articles - BL Direct - All 3 versions

Systemic hemodynamic effects of treatment with the molecular adsorbents …


LE Schmidt, LP Wang, BA Hansen, FS Larsen - Liver transplantation, 2003 - Elsevier
The aim of the study is to evaluate the effect of a single treatment with the molecular adsorbents
recirculating system (MARS) on systemic hemodynamics and oxygen consumption (V 2 ) in patients
with hyperacute liver failure (HALF). In a controlled design, eight patients with HALF were ...
Cited by 93 - Related articles - BL Direct - All 5 versions

Uremic bleeding: closing the circle after 30 years of controversies?


M Noris, G Remuzzi - Blood, 1999 - Am Soc Hematology
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this? ... Uremic Bleeding: Closing the Circle After 30 Years of Controversies? ... From
the Mario Negri Institute for Pharmacological Research, Bergamo, Italy; and the Unit of ...
Cited by 82 - Related articles - BL Direct - All 5 versions

Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric …


L Doughty, JA Carcillo, S Kaplan, J Janosky - Critical care medicine, 1998 - journals.lww.com
From the Departments of Anesthesiology and Critical Care Medicine and Pediatrics (Drs. Doughty
and Carcillo), the Center for Clinical Pharmacology (Dr. Carcillo), and the Departments of Hematology
(Dr. Kaplan) and Family Medicine and Clinical Epidemiology (Dr. Janosky), University of ...
Cited by 78 - Related articles - BL Direct - All 4 versions

Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal …

- cardiovascres.org
AC Mendes Ribeiro, TMC Brunini, JC Ellory, … - Cardiovascular …, 2001 - cardiovascres.org
Patients with chronic renal and heart failure present with hypertension and widespread
vasoconstriction, respectively. Although systemic release of nitric oxide (NO) may be elevated
in both pathological syndromes, enhanced production of NO fails to overcome endothelial ...
Cited by 66 - Related articles - All 5 versions

Blood volume controlled hemodialysis in hypotension-prone patients: a …


A Santoro, E Mancini, C Basile, L Amoroso, S Di Giulio … - Kidney international, 2002 - nature.com
1 Other participants (institutions) include: Rosa Giordano (Ospedale Provinciale Civile, Martina
Franca); Lorenzo Liberato (Ospedale S. Camillo De Lessis, Chieti); Luciano Meschini (Ospedale
GB Grassi, Ostia Lido); Luigi Lucani (Ospedale S. Carlo Borromeo, Milano); Carlo Navino ...
Cited by 58 - Related articles - BL Direct - All 4 versions

Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients

- nih.gov
T Lau, W Owen, YM Yu, N Noviski, J Lyons, … - Journal of Clinical …, 2000 - Am Soc Clin Investig
The kidneys are thought to be a major site of net de novo arginine synthesis, but the quantitative
status of arginine metabolism and its substrate precursor relationship to nitric oxide (NO) synthesis
in end stage renal disease (ESRD) patients have not been characterized. We have ...
Cited by 56 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google